ABT241129C118000
- 1.05
- +0.45+75.00%
Abbott Laboratories Newsroom
'Bunker' and 'Booster' Stocks in the U.S. – Which Would Perform Better in a Downturn Vs. Upturn?
ABT Stock Benefits From First Patient Procedures With TAVI System
Judge Denies Abbott Request for Retrial, Lower Damages in $500M Baby Formula Case
InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors
Express News | InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to Its Board of Directors
TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $130
Strategic Initiatives and Innovations Drive Buy Rating for Abbott Laboratories
Protein Supplements Market Global Forecast Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, Herbalife, Nestle, Simply Good Foods, WK Kellogg, PepsiCo, and Glanbia
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed
Abbott Tests New Balloon-Expandable TAVI System for Aortic Stenosis, Launches First Patient Procedures With Investigational TAVI Device
Express News | Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable Tavi System to Treat Aortic Stenosis
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
Abbott Laboratories (NYSE:ABT) Is Largely Controlled by Institutional Shareholders Who Own 78% of the Company
WHO Extends Mpox Emergency; Canada Reports First Clade I Case
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
Optimism Over Global Healthcare Sector Rises: Jefferies
MACH Alliance Expands Education Program, Appoints Dylan Valade of Abbott As Head of Education
Following the US Secretary of Health, Trump's nomination for the FDA Commissioner seems to be another anti-vaccine advocate.
Makari is a surgeon who opposes overtreatment, advocates for re-evaluating hormone replacement therapy, and reducing the overuse of antibiotics.
Unusual Options Activity: MET, CNH and Others Attract Market Bets, MET V/OI Ratio Reaches 318.2
EST Nov 20th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options